WSNAF Company Profile and Key Details

Q: Who are the executives of WSNAF?

Izzy FormanVice President of CommunicationsMr. Jeffrey T. JewellSenior Vice President of Medical & Scientific AffairsDr. Mark A. Wingertzahn Ph.D.Senior Vice President of R&D and Head of Devel.Mr. Chad BronsteinCo-FounderMr. Zed WangChief Financial Officer & Corporation Sec.Mr. Daniel CarcilloCo-Founder, Chief Executive Officer & ChairmanMr. Keenan GentryVice President of Investor Relations & Corporation Devel.

PNK : WSNAF

Wesana Health

$0.01

-0.0066-46.79%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Wesana Health Holdings Inc. (WSNAF) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.02 during the session.

Stock Snapshot

0.0035

Prev. Close

73.22K

Market Cap

0.0035

Day Low

0.18

P/E Ratio

0.02

EPS (TTM)

-0.06

Cash Flow per Share

Open

20.92M

Number of Shares

0.0163

Day High

98.37%

Free Float in %

0.01

Book Value

15.92K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 28, 2026	0.00	0.00	0.00	0.00	200
Aug 03, 2026	0.00	0.00	0.00	0.00	1.01K
Apr 21, 2026	0.00	0.00	0.00	0.00	100
Mar 06, 2026	0.00	0.00	0.00	0.00	20K
Feb 11, 2026	0.01	0.02	0.01	0.02	16.57K
Feb 09, 2026	0.01	0.01	0.01	0.01	10.34K
Feb 06, 2026	0.02	0.02	0.01	0.01	1.04K
Feb 05, 2026	0.01	0.01	0.01	0.01	4.83K
Feb 04, 2026	0.01	0.01	0.01	0.01	9.99K
Feb 02, 2026	0.01	0.02	0.01	0.02	1.12K
Jan 30, 2026	0.02	0.02	0.02	0.02	135
Jan 29, 2026	0.02	0.02	0.02	0.02	640
Jan 28, 2026	0.01	0.01	0.01	0.01	214
Jan 27, 2026	0.02	0.02	0.02	0.02	1.29K
Jan 26, 2026	0.01	0.01	0.01	0.01	1.95K
Jan 22, 2026	0.01	0.01	0.01	0.01	3.2K
Jan 21, 2026	0.01	0.01	0.01	0.01	5.2K
Jan 20, 2026	0.02	0.02	0.01	0.01	7.1K
Jan 15, 2026	0.02	0.02	0.01	0.01	1.15K
Jan 14, 2026	0.01	0.02	0.01	0.01	7.45K

Contact Details

Chicago, IL 60607

United States

https://www.wesanahealth.com 773 236 7972

About Company

Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI). The company focuses on pioneering scientifically validated compounds and therapeutic strategies. Its mission is to enable patients suffering from trauma-related neurological, psychological, and mental health conditions to achieve recovery. Wesana Health is headquartered in Chicago, Illinois.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Company Overview

The stock is currently mid-range between its 52-week high and low $0.00 and $0.04. With a market capitalization of about $73.22 thousand, Wesana Health Holdings Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.70). Key stats such as the average daily volume over the past year has been around 38.00 shares, trading with heavier-than-usual volume. Headquartered in Chicago, IL, Wesana Health Holdings Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Daniel Carcillo, the company employs approximately 7 people and listed since June 04, 2021. Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI).

Valuation Metrics

Wesana Health Holdings Inc. trades at a P/E ratio of -0.07, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -0.45 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.08, also below market averages.

Dividend & Fair Value

Wesana Health Holdings Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.01. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wesana Health Holdings Inc. earnings surprise history is a mixed track record. The quarter that ended March 29, 2024, missed forecasts by -89.97%. The prior quarter beat by -114.29%. Over the last six quarters, Apple has recorded several small beats. These include -6.25% in May 31, 2022.

Financial & Profitability Overview

Over the trailing twelve months, Wesana Health has not generated any revenue. Returns are negative, with ROA at -444.60% and ROE at -891.01%.
On valuation metrics, Wesana Health trades at a P/E of -0.07, P/S of 0.00 and P/B of -0.45. Liquidity is tight, with a current ratio of 0.49 and quick ratio of 0.49. Debt-to-equity is -0.91, supported by a cash flow-to-debt ratio of -3.48.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2022, Wesana Health posted revenue of $0.00, down slightly from $267.21K in the prior quarter. Operating income was - $2.87M (margin 0.0%). Net income was- $8.60M (EPS $0.00).
The company ended the quarter with $450.59K in cash and short-term investments, a total debt of $295.13K, and net debt of - $151.26K. Total assets were $1.93M, with equity of $0.00. Financials further reflected weakness, with operating cash flow of - $7.69M, free cash flow of - $7.69M, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that Wesana Health Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Wesana Health Holdings Inc. trading at a premium to the broader market with a P/E of -0.07.

Frequently Asked Questions

What is the current Wesana Health Holdings Inc. (WSNAF) stock price?

Wesana Health Holdings Inc. (OTC: WSNAF) stock price is $0.00 in the last trading session. During the trading session, WSNAF stock reached the peak price of $0.02 while $0.00 was the lowest point it dropped to. The percentage change in WSNAF stock occurred in the recent session was 0% while the dollar amount for the price change in WSNAF stock was $0.00.

WSNAF's industry and sector of operation?

The OTC listed WSNAF is part of Biotechnology industry that operates in the broader Healthcare sector. Wesana Health Holdings Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of WSNAF?

Izzy Forman
Vice President of Communications
Mr. Jeffrey T. Jewell
Senior Vice President of Medical & Scientific Affairs
Dr. Mark A. Wingertzahn Ph.D.
Senior Vice President of R&D and Head of Devel.
Mr. Chad Bronstein
Co-Founder
Mr. Zed Wang
Chief Financial Officer & Corporation Sec.
Mr. Daniel Carcillo
Co-Founder, Chief Executive Officer & Chairman
Mr. Keenan Gentry
Vice President of Investor Relations & Corporation Devel.

How WSNAF did perform over past 52-week?

WSNAF's closing price is 166.07% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.04 is -87.16%.

How many employees does WSNAF have?

Number of WSNAF employees currently stands at 7.

Link for WSNAF official website?

Official Website of WSNAF is: https://www.wesanahealth.com

How do I contact WSNAF?

WSNAF could be contacted at phone 773 236 7972 and can also be accessed through its website. WSNAF operates from 433 W Van Buren Street, Chicago, IL 60607, United States.

How many shares of WSNAF are traded daily?

WSNAF stock volume for the day was 15.92K shares. The average number of WSNAF shares traded daily for last 3 months was 38.

What is the market cap of WSNAF currently?

The market value of WSNAF currently stands at $73.22K with its latest stock price at $0.00 and 20.92M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7
Beta	-0.7
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

WSNAF Company Profile and Key Details

Wesana Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways